Spero Therapeutics Inc (SPRO)
1.13
0.00 (0.00%)
USD |
NASDAQ |
Nov 27, 15:37
Spero Therapeutics Shares Outstanding: 54.52M for Nov. 6, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 06, 2024 | 54.52M |
September 30, 2024 | 54.31M |
August 01, 2024 | 54.05M |
June 30, 2024 | 54.01M |
May 06, 2024 | 53.99M |
April 05, 2024 | 53.89M |
April 01, 2024 | 53.87M |
March 31, 2024 | 53.87M |
March 11, 2024 | 53.87M |
March 08, 2024 | 53.87M |
December 31, 2023 | 53.00M |
November 06, 2023 | 53.00M |
September 30, 2023 | 53.00M |
August 11, 2023 | 52.72M |
August 07, 2023 | 52.70M |
June 30, 2023 | 52.57M |
May 01, 2023 | 52.57M |
March 31, 2023 | 52.57M |
March 01, 2023 | 52.57M |
December 31, 2022 | 52.46M |
November 10, 2022 | 51.78M |
November 07, 2022 | 50.31M |
September 30, 2022 | 42.86M |
September 21, 2022 | 38.52M |
August 05, 2022 | 35.07M |
Date | Value |
---|---|
July 20, 2022 | 35.07M |
June 30, 2022 | 35.07M |
May 12, 2022 | 32.82M |
March 31, 2022 | 32.76M |
March 25, 2022 | 32.76M |
December 31, 2021 | 32.39M |
November 05, 2021 | 32.32M |
September 30, 2021 | 32.22M |
July 29, 2021 | 32.15M |
June 30, 2021 | 29.70M |
June 24, 2021 | 29.70M |
June 01, 2021 | 29.68M |
April 29, 2021 | 29.67M |
March 31, 2021 | 29.66M |
March 08, 2021 | 29.50M |
March 05, 2021 | 29.50M |
December 31, 2020 | 29.26M |
November 06, 2020 | 27.20M |
October 29, 2020 | 27.19M |
October 01, 2020 | 27.17M |
September 30, 2020 | 25.97M |
September 15, 2020 | 25.97M |
September 01, 2020 | 21.18M |
July 30, 2020 | 21.15M |
June 30, 2020 | 21.01M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
19.19M
Minimum
Dec 31 2019
54.52M
Maximum
Nov 06 2024
37.83M
Average
32.76M
Median
Mar 25 2022
Shares Outstanding Benchmarks
CytomX Therapeutics Inc | 78.26M |
Johnson & Johnson | 2.408B |
Arbutus Biopharma Corp | 189.49M |
Equillium Inc | 35.43M |
NovaBay Pharmaceuticals Inc | 4.886M |